Diatide's lung cancer diagnostic approved in the US
This article was originally published in Clinica
Executive Summary
The US FDA has approved Diatide's nuclear medicine imaging agent NeoTect, a non-invasive test for lung cancer, which identifies patients who should undergo a biopsy.